First experience using CGM of patients diabetes.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0007691

Enrollment

Registered

2022-09-15

Start date

2022-08-04

Completion date

Unknown

Last updated

2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Trial use of continuous glucose monitoring for 2 weeks

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Those who have been diagnosed with diabetes 2) Those who receive insulin injections or oral blood glucose enhancer treatment at least 1 time per day 3) Adult men and women between the ages of 19 and under 69 years of age 4) Those who have agreed to use CGM for 2 weeks (LibreTM)

Exclusion criteria

Exclusion criteria: 1) Those who cannot use the smartphone app 2) Those who have difficulty in keeping a journal of use 3) Those who are deemed unsuitable for participation in the examination by other research directors 4) Those who have been diagnosed with diabetes and have used it for 2 weeks for testing purposes 5) Patients who need CT, X-ray, MRI scan within 2 weeks of CGM attachment

Design outcomes

Primary

Measure	Time frame
Empowerment, self-management activities, self-efficacy, system usability scale	—

Countries

Korea, Republic of

Contacts

Public ContactYoungran Yang

Jeonbuk National University

youngran13@jbnu.ac.kr+82-63-270-3116

Outcome results